Retreatment of advanced esthesioneuroblastoma with high-activity I-125 endocurietherapy: a case report.

P. P. Kumar, F. P. Ogren, R. D. McComb, E. O. Jones, G. F. McCaul

Research output: Contribution to journalArticle

3 Scopus citations


A 67-year-old woman presented with an advanced esthesioneuroblastoma that recurred 2 years following external irradiation. She was successfully retreated with continuous low-dose rate interstitial irradiation from high-activity I-125 seeds implanted permanently into the tumor.

Original languageEnglish (US)
Pages (from-to)735-738
Number of pages4
JournalJournal of the National Medical Association
Issue number8
StatePublished - Aug 1991


ASJC Scopus subject areas

  • Medicine(all)

Cite this